Straumann's new-generation small-diameter soft-tissue-level implant enters full market release

(PresseBox) ( Phoenix/Basel, )
- New implant offers increased flexibility and additional treatment options
- Combines the exceptional strength of Roxolid®, the fast osseointegration of SLActive® and the reliability and improved handling advantages of the CrossFit® connection
- Full launch in the US, Europe and Australia with other markets[1] to follow

At the Academy of Osseointegration’s annual meeting in Phoenix (USA), Straumann announced that its new-generation, small-diameter, soft-tissue-level implant is now available to customers in the US, Europe and Australia. The new implant, which is called the ‘Straumann® Standard Plus Narrow Neck CrossFit®’ (NNC), is used for tooth replacement in situations, where space or bone is limited. It combines the exceptional strength of Straumann’s Roxolid® material, the fast osseointegration of the SLActive® surface and the reliability and improved handling advantages of Straumann’s CrossFit® connection.

Beat Spalinger, President & CEO of Straumann, commented:

“This implant is the result of continued innovation, development, and refinement to meet medical needs and customer requirements. NNC brings together all our experience in design, technology, and clinical application, combining new and established features to enhance convenience and open up new treatment possibilities. Although it is a product of progressive development over many years, we chose to introduce it prudently through a controlled market release – in the true Straumann way. Having successfully concluded this phase, we are now making it available on a much wider basis.”

Extended treatment options

Small diameter implants are used for limited inter-dental spaces or narrow bone ridges. The NNC is indicated for a variety of uses, including: single-tooth replacement and multiple-tooth replacement with bridges and fixed or removable over-dentures. Being a soft-tissue-level design, the new implant facilitates soft-tissue management and can be placed in a one-step procedure that avoids a second surgical intervention. It is thus designed to simplify treatment and reduces the number of dental visits. The NNC complements Straumann’s small-diameter bone-level implant – no other company is able to offer small-diameter implants made of Roxolid for both soft-tissue-level and bone-level applications.

Roxolid is the key

Roxolid has been the key to the development of the NNC. The material’s physical strength has enabled Straumann to develop a small diameter implant with an internal rather than an external connection. The implant-abutment interface is designed to provide an excellent seal and distribute the biting pressure optimally. It also offers great flexibility for prosthetic angulation.

The SLActive surface

SLActive is one of the best investigated implant surfaces on the market. A multitude of studies have provided scientific evidence endorsing its remarkable properties[2,3] including a marked reduction of healing times[3], improved bone formation[4] and excellent survival rates[5].

Handling simplicity with the CrossFit connection and new transfer piece

Implant dentistry involves working with tiny, high-precision components in restricted, poorly visible spaces. The CrossFit connection, which is used in Straumann’s Bone Level range, is an ingenious solution to this problem because it guides the abutment precisely into the correct position and enables the user literally to ‘feel the fit’. In addition to offering a variety of four positions, the CrossFit connection safeguards against abutment rotation.

The NNC implant is complemented by a broad portfolio of surgical and standard prosthetic components. It also features a new convenient transfer piece, which holds the implant in the surgeon’s drill and is then easily detached from the implant after insertion in the jawbone.

One system, one instrument set

The NNC supersedes Straumann’s existing narrow-neck soft-tissue-level implant, which is made of titanium, has an external hex design, and is only indicated for single-tooth replacement. The new implant has been integrated into Straumann’s Dental Implant System which includes a full range of Soft Tissue and Bone Level options and covers all indications6. In spite of this, the procedures and instruments are the same and only one surgical kit is required.


This release contains certain ‘forward-looking statements’, which can be identified by the use of terminology such as ‘to follow’, ‘will’, ‘supersedes’, or similar wording. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Group to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group’s products, the potential for the Group’s products to become obsolete, the Group’s ability to defend its intellectual property, the Group’s ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group’s ability to generate revenues and profitability, and the Group’s ability to realize its expansion projects in a timely manner. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this report. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise.

[1] Pending regulatory approvals/clearances
[2] Straumann SLActive Scientific Evidence Fifth Edition, 2010
[3] Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL. Enhanced implant stability with a chemically modified SLA surface: a randomized pilot study. Int J Oral Maxillofac Implants 2007;22:755-760.
[4] Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD. Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants Res 2011;22:349-356.
[5] Ganeles J, Zöllner A, Jackowski J, ten Bruggenkate C, Beagle J, Guerra F. Immediate and early loading of Straumann implants with a chemically modified surface (SLActive) in the posterior mandible and maxilla: 1-year results from a prospective multicenter study. Clin Oral Implants Res 2008;19:1119-1128.
[6] From single-tooth to fully edentulous
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to